Farallon Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
SUT
Farallon Capital Management's CELL Position: Q1 2022 in Review
Farallon Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 787,327 shares — an estimated $14.3M sold.
Farallon Capital Management first reported a position in CELL in Q4 2021 and held it in 1 quarter. The position peaked at $14.3M in Q4 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.
- Farallon Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Farallon Capital Management sold 787,327 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $14.3M.
- Farallon Capital Management first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 1 quarter.
- Farallon Capital Management's PhenomeX Inc. Common Stock position peaked at $14.3M in Q4 2021.
- 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.
Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.